Cargando…
Uncovering the pharmacology of Ginkgo biloba folium in the cell-type-specific targets of Parkinson’s disease
Parkinson’s disease (PD) is the second most common neurodegenerative disease with a fast-growing prevalence. Developing disease-modifying therapies for PD remains an enormous challenge. Current drug treatment will lose efficacy and bring about severe side effects as the disease progresses. Extracts...
Autores principales: | Yan, Yu-Chen, Xu, Zhi-Heng, Wang, Jian, Yu, Wen-Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556873/ https://www.ncbi.nlm.nih.gov/pubmed/36249800 http://dx.doi.org/10.3389/fphar.2022.1007556 |
Ejemplares similares
-
Corrigendum: Uncovering the pharmacology of Ginkgo biloba folium in the cell-type-specific targets of Parkinson’s disease with a deep learning algorithm
por: Yan, Yu-Chen, et al.
Publicado: (2023) -
Comprehensive metabolomics and lipidomics profiling uncovering neuroprotective effects of Ginkgo biloba L. leaf extract on Alzheimer’s disease
por: Liu, Li-Wei, et al.
Publicado: (2022) -
A network pharmacology approach to uncover the key ingredients in Ginkgo Folium and their anti-Alzheimer’s disease mechanisms
por: Zeng, Peng, et al.
Publicado: (2021) -
Pharmacological activities and effective substances of the component-based Chinese medicine of Ginkgo biloba leaves based on serum pharmacochemistry, metabonomics and network pharmacology
por: Liang, Hongbao, et al.
Publicado: (2023) -
The Use of Ginkgo Biloba L. as a Neuroprotective Agent in the Alzheimer’s Disease
por: Nowak, Anna, et al.
Publicado: (2021)